Research Article

Biological evaluation and molecular docking of Indonesian Gracilaria salicornia as antioxidant agents

Volume: 27 Number: 1 June 28, 2025

Biological evaluation and molecular docking of Indonesian Gracilaria salicornia as antioxidant agents

Abstract

The antioxidant activity of Gracilaria salicornia extract was investigated to develop natural product-based chemotherapeutic agents using more efficient and straightforward methods. The efficacy was determined through free radical scavenging activity against DPPH, phytochemical assays, GC-MS analysis, and molecular docking analysis through NADPH Oxidase (NOX) protein (PDB ID: 2CDU). The best antioxidant activity of several extracts was shown by ethyl acetate extract with an IC50 value about 179.81±6.38 µg/mL, classified as moderate activity. Based on the phytochemical assay, the extract contains alkaloids, steroids, phenolics, flavonoids, and saponin compounds. Further analysis of the extract by GC-MS showed the presence of secondary metabolites that have been shown to have bioactivity as antioxidant and anticancer agents, such as L-(+)-ascorbic acid 2,6-dihexadecanoate, cholest-5-en-3-ol (3.beta.), 1,2-benzenedicarboxylic acid, and phytol. The activity was also supported by molecular docking analysis. Cholest-5-en-3-ol (3.beta.), 1,2-benzenedicarboxylic acid, and phytol showed outstanding interaction with the target protein's active site (binding energy -10.90, -7.11, and -6.22 kcal/mol, respectively). The binding energy of cholest-5-en-3-ol (3.beta.) was significantly higher than the native ligand. The binding energy describes the potential of the compound to suppress ROS production by inhibiting NOX protein activity. These findings revealed that the phytochemicals of G. salicornia can be developed as a chemotherapeutic agent. This approach can be used as a guide in developing natural product-based chemotherapeutic agents.

Keywords

References

  1. [1 ]Demarinis S. Cancer overtakes cardiovascular disease as leading cause of death in wealthy nations. Explore. 2019;16(1):1-2. [CrossRef]
  2. [2] Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424. [CrossRef]
  3. [3] Pradhan B, Nayak R, Patra S, Jit BP, Ragusa A, Jena M. bioactive metabolites from marine algae as potent pharmacophores against oxidative stress-associated human diseases: A comprehensive review.Molecules. 2020;26(1):37. [CrossRef]
  4. [4] Liang Z, Liang J, Li L, Cen T, Guo H. NADPH oxidase involved in immune response via regulating the expression of antioxidant genes in Litopenaeus vannamei. Aquac Reports. 2021;21:100810. [CrossRef]
  5. [5] Allegra M. Redox systems oxidative stress, and antioxidant defences in health and disease. Antioxidants. 2021;10(1955):1-5. [CrossRef]
  6. [6] Ganguly U, Kaur U, Chakrabarti SS, Ganguly U,Kaur U,Chakrabarti SS,Sharma P,Agrawal BK,Saso L,Chakrabarti S. Oxidative stress, neuroinflammation, and NADPH oxidase: ımplications in the pathogenesis and treatment of alzheimer’s disease. Oxid Med Cell Longev. 2021;2021:1-19. [CrossRef]
  7. [7] Han J, Jin C, Zhong Y, Zhu J,Liu Q,Sun D,Feng J,Xia X,Peng X. Involvement of NADPH oxidase in patulin-induced oxidative damage and cytotoxicity in HEK293 cells. Food Chem Toxicol. 2021;150(January):112055. [CrossRef]
  8. [8] Santos WH dos, Yoguim MI, Daré RG, Da Silva-Filho LC, Lautenschlager SOS, Ximenes VF. Development of a caffeic acid-phthalimide hybrid compound for NADPH oxidase inhibition. RSC Adv. 2021;11(29):17880-17890. [CrossRef]

Details

Primary Language

English

Subjects

Pharmacology and Pharmaceutical Sciences (Other)

Journal Section

Research Article

Publication Date

June 28, 2025

Submission Date

June 19, 2022

Acceptance Date

August 16, 2022

Published in Issue

Year 2023 Volume: 27 Number: 1

APA
Bahrun, B., Okino, T., Rasyid, H., & Soekamto, N. H. (2025). Biological evaluation and molecular docking of Indonesian Gracilaria salicornia as antioxidant agents. Journal of Research in Pharmacy, 27(1), 207-220. https://izlik.org/JA22ZC25YX
AMA
1.Bahrun B, Okino T, Rasyid H, Soekamto NH. Biological evaluation and molecular docking of Indonesian Gracilaria salicornia as antioxidant agents. J. Res. Pharm. 2025;27(1):207-220. https://izlik.org/JA22ZC25YX
Chicago
Bahrun, Bahrun, Tatsufumi Okino, Herlina Rasyid, and Nunuk Hariani Soekamto. 2025. “Biological Evaluation and Molecular Docking of Indonesian Gracilaria Salicornia As Antioxidant Agents”. Journal of Research in Pharmacy 27 (1): 207-20. https://izlik.org/JA22ZC25YX.
EndNote
Bahrun B, Okino T, Rasyid H, Soekamto NH (June 1, 2025) Biological evaluation and molecular docking of Indonesian Gracilaria salicornia as antioxidant agents. Journal of Research in Pharmacy 27 1 207–220.
IEEE
[1]B. Bahrun, T. Okino, H. Rasyid, and N. H. Soekamto, “Biological evaluation and molecular docking of Indonesian Gracilaria salicornia as antioxidant agents”, J. Res. Pharm., vol. 27, no. 1, pp. 207–220, June 2025, [Online]. Available: https://izlik.org/JA22ZC25YX
ISNAD
Bahrun, Bahrun - Okino, Tatsufumi - Rasyid, Herlina - Soekamto, Nunuk Hariani. “Biological Evaluation and Molecular Docking of Indonesian Gracilaria Salicornia As Antioxidant Agents”. Journal of Research in Pharmacy 27/1 (June 1, 2025): 207-220. https://izlik.org/JA22ZC25YX.
JAMA
1.Bahrun B, Okino T, Rasyid H, Soekamto NH. Biological evaluation and molecular docking of Indonesian Gracilaria salicornia as antioxidant agents. J. Res. Pharm. 2025;27:207–220.
MLA
Bahrun, Bahrun, et al. “Biological Evaluation and Molecular Docking of Indonesian Gracilaria Salicornia As Antioxidant Agents”. Journal of Research in Pharmacy, vol. 27, no. 1, June 2025, pp. 207-20, https://izlik.org/JA22ZC25YX.
Vancouver
1.Bahrun Bahrun, Tatsufumi Okino, Herlina Rasyid, Nunuk Hariani Soekamto. Biological evaluation and molecular docking of Indonesian Gracilaria salicornia as antioxidant agents. J. Res. Pharm. [Internet]. 2025 Jun. 1;27(1):207-20. Available from: https://izlik.org/JA22ZC25YX